For patients who suffer from leukemia or other blood diseases, a stem cell transplant frequently offers the best chance of survival. Such a transplant is likely to be a life saving event. According to the website of the London Health Sciences Center [4] “Long-term survival may be greater than 80 per cent,... depend-ing on the type of disease treated, the patient’s age, and the severity of illness. For patients with acute leukemia, long-term survival is 50-60 per cent but this is much better than 20-25 per cent survival when patients are treated with chemotherapy alone.... recipients eventually return to a normal lifestyle.” Human bone marrow contains blood-forming stem cells that are destroyed by heavy doses of chemotherapy. These cells, wh...
Background: The aim of this study was to determine the value of upfront autologous transplantation (...
Fifty patients affected by sickle cell anaemia underwent transplantation of HLA-identical haematopoi...
Contains fulltext : 87519.pdf (publisher's version ) (Open Access)BACKGROUND: Allo...
For patients who suffer from leukemia or other blood diseases, a stem cell transplant frequently off...
patients who suffer from leukemia or other blood diseases, a stem cell transplant fre-quently offers...
Transplants of donated stem cells save the lives of many patients with blood diseases. Donation is s...
Item does not contain fulltextIn December 2000, the Bone Marrow DonorBank Europdonor Nijmegen in The...
PURPOSE: In the two consecutive German studies III and IIIA on chronic myeloid leukemia, between 199...
BACKGROUND: Allogeneic stem cell transplantation (alloSCT) reduces relapse rates in acute leukemia, ...
Stem cell transplants have become common treatment for certain types of cancer including multiple my...
Hematopoietic stem cell transplantation is the sole curative therapy for sickle cell anemia (SCA). T...
Advancements raise every day in cancer therapy to save human life. Transplantation of bone marrow is...
We previously compared outcomes after allogeneicperipheral-bloodstemcell (PBSC) and bone marrow (BM)...
AbstractWe sought to determine whether differences in chronic graft-versus-host disease (GVHD) rates...
This study has discovered a new mechanism that involves inhibiting the organelle, the lysosome, and ...
Background: The aim of this study was to determine the value of upfront autologous transplantation (...
Fifty patients affected by sickle cell anaemia underwent transplantation of HLA-identical haematopoi...
Contains fulltext : 87519.pdf (publisher's version ) (Open Access)BACKGROUND: Allo...
For patients who suffer from leukemia or other blood diseases, a stem cell transplant frequently off...
patients who suffer from leukemia or other blood diseases, a stem cell transplant fre-quently offers...
Transplants of donated stem cells save the lives of many patients with blood diseases. Donation is s...
Item does not contain fulltextIn December 2000, the Bone Marrow DonorBank Europdonor Nijmegen in The...
PURPOSE: In the two consecutive German studies III and IIIA on chronic myeloid leukemia, between 199...
BACKGROUND: Allogeneic stem cell transplantation (alloSCT) reduces relapse rates in acute leukemia, ...
Stem cell transplants have become common treatment for certain types of cancer including multiple my...
Hematopoietic stem cell transplantation is the sole curative therapy for sickle cell anemia (SCA). T...
Advancements raise every day in cancer therapy to save human life. Transplantation of bone marrow is...
We previously compared outcomes after allogeneicperipheral-bloodstemcell (PBSC) and bone marrow (BM)...
AbstractWe sought to determine whether differences in chronic graft-versus-host disease (GVHD) rates...
This study has discovered a new mechanism that involves inhibiting the organelle, the lysosome, and ...
Background: The aim of this study was to determine the value of upfront autologous transplantation (...
Fifty patients affected by sickle cell anaemia underwent transplantation of HLA-identical haematopoi...
Contains fulltext : 87519.pdf (publisher's version ) (Open Access)BACKGROUND: Allo...